Ohio Public Employees Retirement System (OPERS)’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-221,421	Closed	-$2.48M	–	1913
2017 Q3	$2.48M	Buy	+221,421	New	+$2.44M	0.01%	921
2017 Q2	–	Sell	-43,410	Closed	-$425K	–	1924
2017 Q1	$425K	Hold	43,410	–	–	﹤0.01%	1361
2016 Q4	$428K	Buy	43,410 +21,069	+94%	+$211K	﹤0.01%	1359
2016 Q3	$229K	Buy	22,341 +8,542	+62%	+$93K	﹤0.01%	1448
2016 Q2	$180K	Hold	13,799	–	–	﹤0.01%	1409
2016 Q1	$152K	Sell	13,799 -1,249	-8%	-$11.1K	﹤0.01%	1430
2015 Q4	$138K	Sell	15,048 -13,479	-47%	-$113K	﹤0.01%	1458
2015 Q3	$198K	Buy	+28,527	New	+$244K	﹤0.01%	1438

Ohio Public Employees Retirement System (OPERS)'s SCLN Position: Q4 2017 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 221,421 shares — an estimated $2.48M sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in SCLN in Q3 2015 and held it in 8 quarters. The position peaked at $2.48M in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Ohio Public Employees Retirement System (OPERS) reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 221,421 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $2.48M.
Ohio Public Employees Retirement System (OPERS) first reported a position in Sciclone Pharmaceuticals Inc in Q3 2015 and held it in 8 quarters.
Ohio Public Employees Retirement System (OPERS)'s Sciclone Pharmaceuticals Inc position peaked at $2.48M in Q3 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2017, filed 8 Feb 2018.